Patents by Inventor Milla Koistinaho

Milla Koistinaho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heteroarylamide derivatives having antiandrogenic properties
    Patent number: 9650382
    Abstract: The invention relates to novel heteroarylamide derivatives having formula (I) and N-oxides, stereoisomers and pharmaceutically acceptable salts thereof, where RA, RB, R1 1, R?, R?, z and X are as defined in the claims. The arylamide derivatives of formula (I) have antiandrogenic properties. The invention also relates to compounds of formula (I) for use as a medicament and to pharmaceutical compositions comprising them and to their preparation.
    Type: Grant
    Filed: January 11, 2013
    Date of Patent: May 16, 2017
    Assignee: ARANDA PHARMA LTD
    Inventors: Jari Ratilainen, Milla Koistinaho, Anu Muona
  • NOVEL HETEROARYLAMIDE DERIVATIVES HAVING ANTIANDROGENIC PROPERTIES
    Publication number: 20150005308
    Abstract: The invention relates to novel heteroarylamide derivatives having formula (I) and N-oxides, stereoisomers and pharmaceutically acceptable salts thereof, where RA, RB, R1 1, R?, R?, z and X are as defined in the claims. The arylamide derivatives of formula (I) have antiandrogenic properties. The invention also relates to compounds of formula (I) for use as a medicament and to pharmaceutical compositions comprising them and to their preparation.
    Type: Application
    Filed: January 11, 2013
    Publication date: January 1, 2015
    Inventors: Jari Ratilainen, Milla Koistinaho, Anu Muona
  • Arylamide derivatives having antiandrogenic properties
    Patent number: 8816119
    Abstract: The invention relates to novel arylamide derivatives having formula (I) and stereoisomers and pharmaceutically acceptable salts thereof, where R1-R11, R?, R?, z and X are as defined in the claims. The arylamide derivatives of formula (I) have antiandrogenic properties. The invention also relates to compounds of formula (I) for use as a medicament and to pharmaceutical compositions comprising them and to their preparation.
    Type: Grant
    Filed: July 14, 2011
    Date of Patent: August 26, 2014
    Assignee: Medeia Therapeutics Ltd
    Inventors: Jari Ratilainen, Milla Koistinaho, Anu Muona
  • NOVEL ARYLAMIDE DERIVATIVES HAVING ANTIANDROGENIC PROPERTIES
    Publication number: 20130109750
    Abstract: The invention relates to novel arylamide derivatives having formula (I) and stereoisomers and pharmaceutically acceptable salts thereof, where R1-R11, R?, R?, z and X are as defined in the claims. The arylamide derivatives of formula (I) have antiandrogenic properties. The invention also relates to compounds of formula (I) for use as a medicament and to pharmaceutical compositions comprising them and to their preparation.
    Type: Application
    Filed: July 14, 2011
    Publication date: May 2, 2013
    Applicant: MEDEIA THERAPEUTICS LTD
    Inventors: Jari Ratilainen, Milla Koistinaho, Anu Muona
  • METHOD FOR STIMULATING MAMMALIAN CELLS AND MAMMALIAN CELL
    Publication number: 20110104102
    Abstract: The current invention relates to methods for stimulating mammalian cells to enhance their ability to cross the blood-brain-barrier and to phagocytose and degrade beta-amyloid plaques in the brain. The current invention also relates to cells obtained by the method of the invention. The current invention also relates to methods for prevention and treatment of amyloid-accumulating disorders.
    Type: Application
    Filed: January 7, 2011
    Publication date: May 5, 2011
    Applicant: MEDEIA THERAPEUTICS LTD
    Inventors: Jeri KOISTINAHO, Milla KOISTINAHO
  • Method for Stimulating Mammalian Cells and Mammalian Cell
    Publication number: 20080014178
    Abstract: The current invention relates to methods for stimulating mammalian cells to enhance their ability to cross the blood-brain-barrier and to phagocytose and degrade beta-amyloid plaques in the brain. The current invention also relates to cells obtained by the method of the invention. The current invention also relates to methods for prevention and treatment of amyloid-accumulating disorders.
    Type: Application
    Filed: June 17, 2005
    Publication date: January 17, 2008
    Inventors: Jari Koistinaho, Milla Koistinaho